These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 22243419)
1. Different effect of hydrogelation on antifouling and circulation properties of dextran-iron oxide nanoparticles. Karmali PP; Chao Y; Park JH; Sailor MJ; Ruoslahti E; Esener SC; Simberg D Mol Pharm; 2012 Mar; 9(3):539-45. PubMed ID: 22243419 [TBL] [Abstract][Full Text] [Related]
2. High-relaxivity superparamagnetic iron oxide nanoworms with decreased immune recognition and long-circulating properties. Wang G; Inturi S; Serkova NJ; Merkulov S; McCrae K; Russek SE; Banda NK; Simberg D ACS Nano; 2014 Dec; 8(12):12437-49. PubMed ID: 25419856 [TBL] [Abstract][Full Text] [Related]
3. Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. Simberg D; Park JH; Karmali PP; Zhang WM; Merkulov S; McCrae K; Bhatia SN; Sailor M; Ruoslahti E Biomaterials; 2009 Aug; 30(23-24):3926-33. PubMed ID: 19394687 [TBL] [Abstract][Full Text] [Related]
4. Direct recognition of superparamagnetic nanocrystals by macrophage scavenger receptor SR-AI. Chao Y; Karmali PP; Mukthavaram R; Kesari S; Kouznetsova VL; Tsigelny IF; Simberg D ACS Nano; 2013 May; 7(5):4289-98. PubMed ID: 23614696 [TBL] [Abstract][Full Text] [Related]
5. Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake. Inturi S; Wang G; Chen F; Banda NK; Holers VM; Wu L; Moghimi SM; Simberg D ACS Nano; 2015 Nov; 9(11):10758-68. PubMed ID: 26488074 [TBL] [Abstract][Full Text] [Related]
6. Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30 nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture. Yu M; Huang S; Yu KJ; Clyne AM Int J Mol Sci; 2012; 13(5):5554-5570. PubMed ID: 22754315 [TBL] [Abstract][Full Text] [Related]
7. Dextran-Coated Iron Oxide Nanoparticles as Biomimetic Catalysts for Localized and pH-Activated Biofilm Disruption. Naha PC; Liu Y; Hwang G; Huang Y; Gubara S; Jonnakuti V; Simon-Soro A; Kim D; Gao L; Koo H; Cormode DP ACS Nano; 2019 May; 13(5):4960-4971. PubMed ID: 30642159 [TBL] [Abstract][Full Text] [Related]
9. High impact of in situ dextran coating on biocompatibility, stability and magnetic properties of iron oxide nanoparticles. Shaterabadi Z; Nabiyouni G; Soleymani M Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():947-956. PubMed ID: 28415550 [TBL] [Abstract][Full Text] [Related]
10. Contact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivo. Simberg D; Zhang WM; Merkulov S; McCrae K; Park JH; Sailor MJ; Ruoslahti E J Control Release; 2009 Dec; 140(3):301-5. PubMed ID: 19508879 [TBL] [Abstract][Full Text] [Related]
11. Physical characterization and in vivo organ distribution of coated iron oxide nanoparticles. Sharma A; Cornejo C; Mihalic J; Geyh A; Bordelon DE; Korangath P; Westphal F; Gruettner C; Ivkov R Sci Rep; 2018 Mar; 8(1):4916. PubMed ID: 29559734 [TBL] [Abstract][Full Text] [Related]
12. Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Tassa C; Shaw SY; Weissleder R Acc Chem Res; 2011 Oct; 44(10):842-52. PubMed ID: 21661727 [TBL] [Abstract][Full Text] [Related]
13. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging. Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560 [TBL] [Abstract][Full Text] [Related]
14. Dextran-coated iron oxide nanoparticle for delivery of miR-29a to breast cancer cell line. Yalcin S Pharm Dev Technol; 2019 Oct; 24(8):1032-1037. PubMed ID: 31159615 [TBL] [Abstract][Full Text] [Related]
15. Dextran-Benzoporphyrin Derivative (BPD) Coated Superparamagnetic Iron Oxide Nanoparticle (SPION) Micelles for T Yan L; Luo L; Amirshaghaghi A; Miller J; Meng C; You T; Busch TM; Tsourkas A; Cheng Z Bioconjug Chem; 2019 Nov; 30(11):2974-2981. PubMed ID: 31661959 [TBL] [Abstract][Full Text] [Related]
16. Radiation dose rate affects the radiosensitization of MCF-7 and HeLa cell lines to X-rays induced by dextran-coated iron oxide nanoparticles. Khoshgard K; Kiani P; Haghparast A; Hosseinzadeh L; Eivazi MT Int J Radiat Biol; 2017 Aug; 93(8):757-763. PubMed ID: 28452253 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of dextran stabilized superparamagnetic iron oxide nanoparticles for in vivo MR imaging of liver fibrosis. Saraswathy A; Nazeer SS; Nimi N; Arumugam S; Shenoy SJ; Jayasree RS Carbohydr Polym; 2014 Jan; 101():760-8. PubMed ID: 24299836 [TBL] [Abstract][Full Text] [Related]
18. Role of carbohydrate receptors in the macrophage uptake of dextran-coated iron oxide nanoparticles. Chao Y; Karmali PP; Simberg D Adv Exp Med Biol; 2012; 733():115-23. PubMed ID: 22101717 [TBL] [Abstract][Full Text] [Related]
19. Accelerated Blood Clearance Phenomenon Reduces the Passive Targeting of PEGylated Nanoparticles in Peripheral Arterial Disease. Im HJ; England CG; Feng L; Graves SA; Hernandez R; Nickles RJ; Liu Z; Lee DS; Cho SY; Cai W ACS Appl Mater Interfaces; 2016 Jul; 8(28):17955-63. PubMed ID: 27340833 [TBL] [Abstract][Full Text] [Related]
20. Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Cole AJ; David AE; Wang J; Galbán CJ; Hill HL; Yang VC Biomaterials; 2011 Mar; 32(8):2183-93. PubMed ID: 21176955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]